Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung.
Saved in:
| Title: | Engineered Fenretinide- and Tocilizumab-Releasing Janus Nanoparticles for Site-Directed Immunochemoprevention of Squamous Cell Carcinoma of the Lung. |
|---|---|
| Authors: | Wang, Daren1 (AUTHOR), Chang, Albert2,3 (AUTHOR), Shea, Fortune1,3 (AUTHOR), He, Yifei2,4 (AUTHOR), Spinney, Richard4,5 (AUTHOR), Whitsett, Jonathan D.1,6 (AUTHOR), Lahann, Joerg2,3,5,6,7 (AUTHOR), Mallery, Susan R.1,7 (AUTHOR) mallery.1@osu.edu |
| Source: | Pharmaceutics. Nov2025, Vol. 17 Issue 11, p1471. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
